Skip to main content
. 2018 Jun 28;136(9):981–986. doi: 10.1001/jamaophthalmol.2018.2466

Table 1. Survival Rates After Diagnosis of Metastasis by Metastasis Treatment Status.

Period Post–Metastasis Diagnosis, mo Participants Alive, % (95% CI) Difference in Survival Rates, % (95% CI) P Value
No Metastasis Treatment Treatment for Metastasis
Overall Survival Rates (Initial Diagnosis and Treatment)
1982-2009 12 5.6 (2.89-9.62) 30.2 (25.35-35.23) 24.6 (22.46-25.61) <.001
24 1.1 (0.22-2.86) 12.2 (8.91-16.02) 11.1 (8.69-13.16)
Survival Rates by Decade of Initial Diagnosis and Treatment
1982-1991 12 6.25 (2.76-11.76) 29.9 (23.61-36.42) 23.65 (20.85-24.66) <.001
24 0.89 (0.22-2.86) 11.34 (7.37-16.25) 10.45 (7.15-13.39)
1992-2001 12 3.67 (0.68-11.18) 31.73 (23.05-40.74) 28.06 (22.37-29.56) <.001
24 a 14.42 (8.49-21.86) 14.42 (8.49-21.86)
2002-2009 12 6.52 (0.68-11.18) 27.08 (13.07-43.24) 20.56 (12.39-32.06) .004
24 6.52 9.03 (1.69-24.23) 2.51 (1.21-0.53)
Survival Rates by Decade After Metastasis Diagnosis
1982-1991 12 3.08 (0.58-9.51) 22.8 (15.98-30.44) 19.72 (15.4-20.93) <.001
24 1.54 (0.13-7.28) 6.3 (2.95-11.43) 4.76 (2.82-4.15)
1992-2001 12 7.35 (3.00-14.31) 37.5 (29.41-45.56) 30.15 (26.41-31.25) <.001
24 a 17.65 (11.78-24.49) 17.65 (11.78-24.49)
2002-2011 12 5.68 (1.06-16.42) 29.45 (19.03-40.62) 23.77 (17.97-24.2) <.001
24 2.84 (0.22-12.51) 12.21 (5.49-21.79) 9.37 (5.27-9.28)
a

Zero participants were alive.